Liotta, Petricoin Using Protein Array Technology to Test Gleevec for Colorectal Cancer

The GMU researchers and their collaborators are in the midst of a clinical trial that they said is one of the first applications of proteomics technology for personalized medicine.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.